The Role of Epstein–Barr Virus Molecular Mimicry in Various Autoimmune Diseases
Authors:
- 28 March 2025
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (4)
Abstract
Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and multiple sclerosis (MS) are complex autoimmune inflammatory diseases influenced by genetic, environmental and infectious agents like Epstein–Barr virus (EBV). EBV has been proposed to impact immune pathways through molecular mimicry, diverting antibody reactivity towards host tissues. This review explores the literature on EBV‐specific similarities with human peptides and cytokines that might contribute to the onset of RA, SLE and MS. In conclusion, it is vital to conduct experimental computational analyses focusing on the homology between EBV and human proteins to unravel the complexities of autoimmune diseases and advance therapeutic approaches. These insights highlight the significance of collaborative efforts and diverse clinical studies for validation, linking the gap between research and practical applications in the complex field of autoimmunity.Keywords
This publication has 89 references indexed in Scilit:
- Antibody Responses to Epstein‐Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation CyclesArthritis & Rheumatology, 2022
- The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysisClinical and Experimental Medicine, 2018
- Characterization of continuous monoclonal antibody epitopes in the N‐terminus of Ro60Peptide Science, 2015
- Molecular Mimicry as a Mechanism of Autoimmune DiseaseClinical Reviews in Allergy & Immunology, 2011
- The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trialsRheumatology International, 2010
- What is after cytokine-blocking therapy, a novel therapeutic target — Synovial Epstein-Barr virus for rheumatoid arthritisAutoimmunity Reviews, 2007
- Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reactionArthritis & Rheumatism, 2003
- The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin diseaseEuropean Journal of Immunology, 2001
- Lytic Epstein‐Barr virus infection in the synovial tissue of patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspectsRheumatology International, 1989